Impact of commonly used medications on the detection of clinically significant prostate cancer in the targeted biopsy era
This pilot study shows no difference in csPCa detection rates in patients using anti-inflammatories or drugs that alter prostate blood flow.
Authors
- Krista Brackman
Institutions
- University of Wisconsin–Madison (US)
- Wisconsin Division of Public Health (US)
Publication Details
- Journal
- American Journal of Clinical and Experimental Urology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/iwzf5622
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00